Type 2 Diabetes at a Military Health Centre in Brazil: Clinical and Pharmacotherapeutic Profile

Abstract

Objective: To analyze the clinical and pharmacotherapeutic profile of people with type 2 diabetes (T2D) at a military health center in Brazil. Materials and methods: This is a cross-sectional study. The sample of 170 medical records was selected by means of probabilistic sampling. The data collected were sociodemographic, clinical and laboratory data related to diabetes, as well as prescribed medications. Results: Most of the subjects were male (57.6%), elderly (64.7%) and inactive military (55.2%). Adequate glycemic control was observed in 75.9% of the subjects, which was positively associated with multimorbidity and mono-therapeutic treatment (p < 0.05). Negative associations were observed in those subjects attending medical appointments less frequently and using prescribed insulin (p < 0.05). Medications prescribed for treatment of T2D were the following: metformin (90.6%), sulfonylureas (22.9%), dipeptidyl peptidase inhibitors-4 (16.5%) and sodium-glucose 2 co-transporter inhibitors (10.0%), in which 50.6% were monotherapy. Multimorbidity was 97.6%, in which systemic arterial hypertension (71.8%), lipid disorders (65.9%) and cardiovascular diseases (26.5%) were the main clinical conditions. Conclusions: The frequency of inadequate glycemic control among subjects using prescribed insulin shows the importance of monitoring this population by means of insulin dosage adjustment, stimuli for pharmacological measures, including education on diabetes. (Clin Diabetol 2024; 13, 1: 60–66)